Policy briefing on the reform of volume-based procurement of drugs and high-value medical consumables
China SCIO | February 11, 2022
Li Maozhong, a person in charge of the Department of Drug Regulation of the National Medical Products Administration, attends a policy briefing in Beijing on Feb. 11, 2022. [Photo by Xu Xiang/China SCIO]
MORE FROM China SCIO
